Citadel Advisors’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12M | Buy |
|
|||||
|
2025
Q2 | $7.44M | Buy |
|
|||||
|
2025
Q1 | $2.1M | Sell |
|
|||||
|
2024
Q4 | $2.44M | Sell |
|
|||||
|
2024
Q3 | $3.07M | Buy |
|
|||||
|
2024
Q2 | $1.25M | Buy |
|
|||||
|
2024
Q1 | $1.08M | Sell |
|
|||||
|
2023
Q4 | $2.16M | Buy |
|
|||||
|
2023
Q3 | $98K | Sell |
|
|||||
|
2023
Q2 | $497K | Sell |
|
|||||
|
2023
Q1 | $713K | Buy |
|
|||||
|
2022
Q4 | $434K | Buy |
|
|||||
|
2022
Q3 | $114K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $964K | Sell |
|
|||||
|
2021
Q2 | $1.05M | Buy |
|
|||||
|
2021
Q1 | $739K | Buy |
|
|||||
|
2020
Q4 | $655K | Buy |
|
|||||
|
2020
Q3 | $481K | Buy |
|
|||||
|
2020
Q2 | $548K | Sell |
|
|||||
|
2020
Q1 | $1.22M | Sell |
|
|||||
|
2019
Q4 | $2.46M | Sell |
|
|||||
|
2019
Q3 | $2.26M | Sell |
|
|||||
|
2019
Q2 | $3.66M | Sell |
|
|||||
|
2019
Q1 | $6.27M | Sell |
|
|||||
|
2018
Q4 | $16.1M | Buy |
|
|||||
|
2018
Q3 | $17.7M | Buy |
|
|||||
|
2018
Q2 | $16M | Buy |
|
|||||
|
2018
Q1 | $4.04M | Buy |
|